Biokrypton Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Sanand, Gujarat, India, established in 2023.
2023 Sanand, Gujarat, India Active
Last Updated:
About Biokrypton Pharmaceutical Private Limited

Biokrypton Pharmaceutical Private Limited, a active private limited company, was established on 21 March 2023 in Sanand, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U47721GJ2023PTC139413. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Juned Ahemed Patel (Director), Surendra Baid (Director). Past directors included Parshwa Ashishbhai Andhariya. Its latest AGM occurred on 05 November 2024, with the balance sheet filed on 31 March 2024. It is based at 3, Skyline Infrahub, Behind Intas Pharma, Matoda Patia Changodar, Sanand, Gujarat, 382210.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721GJ2023PTC139413

  • Registration Number

    139413

  • Incorporation Date

    21 March 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Biokrypton Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Biokrypton Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Biokrypton Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Juned Ahemed Patel Director 21 Mar 2023 Current
Surendra Baid Director 21 Mar 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Nov 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biokrypton Pharmaceutical.

Enhance accessibility to Biokrypton Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Biokrypton Pharmaceutical revenue growth over time
Biokrypton Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biokrypton Pharmaceutical?

Unlock access to Biokrypton Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Biokrypton Pharmaceutical?

Unlock and access historical data on people associated with Biokrypton Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biokrypton Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biokrypton Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biokrypton Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Biokrypton Pharmaceutical Private Limited last Annual general meeting of members was held on 05 Nov 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Biokrypton Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.

  • Director Appointment

    Progress on Juned Ahemed Patel was appointed as a Director was appointed as a Director on 21 Mar 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Director Appointment

    Surendra Baid was appointed as a Director was appointed as a Director on 21 Mar 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Biokrypton Pharmaceutical Private Limited was registered on 21 Mar 2023 with Roc Ahmedabad & aged 2 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biokrypton Pharmaceutical Private Limited?

The CIN of Biokrypton Pharmaceutical Private Limited is U47721GJ2023PTC139413.

Where is Biokrypton Pharmaceutical Private Limited headquartered?

Biokrypton Pharmaceutical Private Limited is headquartered at 3, Skyline Infrahub, Behind Intas Pharma, Matoda Patia Changodar, Sanand, Gujarat, 382210.

When was Biokrypton Pharmaceutical Private Limited incorporated?

Biokrypton Pharmaceutical Private Limited was incorporated on 21 March 2023.

Who are the current directors of Biokrypton Pharmaceutical Private Limited?

The current directors of Biokrypton Pharmaceutical Private Limited are

What is the primary industry of Biokrypton Pharmaceutical Private Limited?

The primary industry of Biokrypton Pharmaceutical Private Limited is Pharma.

Is Biokrypton Pharmaceutical Private Limited a listed company?

Biokrypton Pharmaceutical Private Limited is unlisted.

What is the capital structure of Biokrypton Pharmaceutical Private Limited?

The authorized capital of Biokrypton Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available